WHO ICTRP trial
A Clinical Trial for the Evaluation of the Efficacy and Safety of AB2025Cg on…
KCT0011236 · Clinical Research Information Service (CRIS) · Not Recruiting
Key facts
| Trial ID | KCT0011236 |
|---|---|
| Public title | A Clinical Trial for the Evaluation of the Efficacy and Safety of AB2025Cg on Improving Cognitive Function |
| Scientific title | A 12-week, Randomized, Double-blind, Placebo-controlled Clinical Trial for the Evaluation of the Efficacy and Safety of AB2025Cg on Improving Cognitive Function in Individuals with Mild Cognitive Impairment |
| Primary sponsor | AceBiome Inc. |
| Registry | Clinical Research Information Service (CRIS) |
| Recruitment status | Not Recruiting |
| Study type | Interventional Study |
| Phase | Not applicable |
| Countries | Korea, Republic of |
| Conditions | Not Applicable |
| Interventions | Dietary Supplement : Participants will consume the assigned investigational product (IP) once daily, 500 mg per capsule, for 12 weeks according to the randomly assigned group. Intervention group: Receives AB2025Cg Placebo control group… |
| Registration date | Dec 1, 2025 |
| Target size | 30 |
| Registry page | cris.nih.go.kr |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: